Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00337740
Status:
TERMINATED
Last Update Posted:
2012-04-23
First Post:
2006-06-14
Brief Title:
Banding Versus Propranolol for Primary Prophylaxis of Variceal Bleeding
Sponsor:
University of Padova
Organization:
University of Padova
Study Overview
Official Title:
Randomized Study Comparing Ligation With Propranolol for Primary Prophylaxis of Variceal Bleeding in Candidates for Liver Transplantation
Status:
TERMINATED
Status Verified Date:
2006-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
From the interim analysis resulted that more than 1000 patients were required to demonstrate a significant difference between the 2 treatments
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Whether beta-blockers or banding is the best therapy for primary prophylaxis of variceal bleeding is subject to debate A randomized comparison between the two treatments was performed in candidates for liver transplantation Patients with Child B and C cirrhosis with high risk varices and no previous variceal bleeding are randomized to propranolol or variceal bleeding Primary end point is variceal bleeding
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None